1. Home
  2. HRMY

HRMY

Harmony Biosciences Holdings Inc.

Logo Harmony Biosciences Holdings Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 3:57pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

Founded: 2017 Country:
United States
United States
Employees: N/A City: PLYMOUTH MEETING
Market Cap: 1.7B IPO Year: 2020
Target Price: $43.78 AVG Volume (30 days): 367.1K
Analyst Decision: Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.13 EPS Growth: -28.28
52 Week Low/High: $18.61 - $39.27 Next Earning Date: 04-30-2024
Revenue: $582,022,000 Revenue Growth: 32.93%
Revenue Growth (this year): 24.74% Revenue Growth (next year): 18.10%

Share on Social Networks: